Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
European Journal of Immunology|October 1, 2008
Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivoRachel Perret, Franca Ronchese
Oncoimmunology|December 20, 2013
Monocyte-derived dendritic cells: Emerging players in the antitumor immune responseSabine Kuhn, Franca Ronchese
Journal of Immune Based Therapies and Vaccines|July 31, 2007
CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansionAnders E Pedersen, Franca Ronchese
Cellular & Molecular Immunology|May 21, 2020
Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responsesKerry L Hilligan, Franca Ronchese
European Journal of Immunology|June 2, 2022
IL-13 in dermal type-2 dendritic cell specialization: From function to therapeutic targetingOlivier Lamiable, Maia Brewerton, Franca Ronchese
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Resting B cells suppress tumor immunity via an MHC class-II dependent mechanismVictoria Watt, Franca Ronchese, David Ritchie
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivoKate A Andrew, Helen M A Simkins, Sabine Witzel, et al.
International Immunology|August 25, 2004
IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivoJoanna M Roberts, Jianping Yang, Franca Ronchese
Current Opinion in Immunology|May 11, 2020
Dendritic cells and the skin environmentFranca Ronchese, Kerry L Hilligan, Johannes U Mayer
Pageof 15